PRLD
(NASDAQ)Prelude Therapeutics Incorporated
---- (--)
Loading... - Market loading
Prelude Therapeutics Incorporated (PRLD) Stock Price & Financial Analysis
Prelude Therapeutics Incorporated Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$2.07 - $2.23
52-Week High$4.22
52-Week Low$0.61
Open$2.22
Volume102.62K
Average Volume (3M)102.62K
Market Cap160.64M
Shares Outstanding76.13M
Price to Sales (P/S)11.90
Price to Book (P/B)2.74
EV/EBITDA-1.10
Revenue (TTM)13.50M
Net Income (TTM)-111.77M
Free Cash Flow (TTM)-100.28M
EPS (TTM)$-1.47
Profit Margin-827.94%
Operating Margin-896.66%
Return on Equity (ROE)-190.95%
Debt to Equity0.31
50-Day MA$2.14
200-Day MA$1.39
52-Week Change117.53%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$2.07 - $2.23
52-Week High$4.22
52-Week Low$0.61
Open$2.22
Volume102.62K
Average Volume (3M)102.62K
Market Cap160.64M
Shares Outstanding76.13M
Price to Sales (P/S)11.90
Price to Book (P/B)2.74
EV/EBITDA-1.10
Revenue (TTM)13.50M
Net Income (TTM)-111.77M
Free Cash Flow (TTM)-100.28M
EPS (TTM)$-1.47
Profit Margin-827.94%
Operating Margin-896.66%
Return on Equity (ROE)-190.95%
Debt to Equity0.31
50-Day MA$2.14
200-Day MA$1.39
52-Week Change117.53%
Annual Dividend$0.00
Dividend Yield0.00%
Latest News
Recent news and articles about PRLD